Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Sootome H, Fujita H, Ito K, Ochiiwa H, et al. Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors. Cancer Res 2020;80:4986-4997.
PMID: 32973082


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016